News
The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
The Associated Press on MSN6d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
StockStory.org on MSN1d
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5% ...
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...
The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.
Moderna reiterated its full-year 2025 product sales forecast of $1.5 billion to $2.5 billion, with most expected in the ...
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results